1. |
- Li, W.B., et al.
(författare)
-
Mechanisms of indentation creep
- 1991
-
Ingår i: Acta Metallurgica et Materialia. - 0956-7151. ; 39:12, s. 3099-3110
-
Tidskriftsartikel (refereegranskat)abstract
- A physically-based theoretical model is developed for describing the phenomenon of indentation creep over the whole temperature range, from 300 K to melting. In agreement with experimental data collected, the model predicts that most materials, including ceramics, exhibit indentation creep at temperatures down to 300 K. It is established that the principal mechanism causing indentation creep is dislocation glide plasticity. The dominance of this mechanism over the whole temperature range is due to the very high stresses involved in indentation creep. If, however, the grain size is small (typically less than 0.3-0.4 μm) indentation creep may be dominated by grain boundary (Coble) diffusive creep instead. The implications of these results in terms of the design, forming and application of the so-called "hard materials" is discussed.
|
|
2. |
- Rajewsky, N., et al.
(författare)
-
LifeTime and improving European healthcare through cell-based interceptive medicine
- 2020
-
Ingår i: Nature. - : Springer Nature. - 0028-0836 .- 1476-4687. ; 587:7834, s. 377-386
-
Tidskriftsartikel (refereegranskat)abstract
- LifeTime aims to track, understand and target human cells during the onset and progression of complex diseases and their response to therapy at single-cell resolution. This mission will be implemented through the development and integration of single-cell multi-omics and imaging, artificial intelligence and patient-derived experimental disease models during progression from health to disease. Analysis of such large molecular and clinical datasets will discover molecular mechanisms, create predictive computational models of disease progression, and reveal new drug targets and therapies. Timely detection and interception of disease embedded in an ethical and patient-centered vision will be achieved through interactions across academia, hospitals, patient-associations, health data management systems and industry. Applying this strategy to key medical challenges in cancer, neurological, infectious, chronic inflammatory and cardiovascular diseases at the single-cell level will usher in cell-based interceptive medicine in Europe over the next decade.
|
|